Table S3 reveals that the base model plus lncRNA546 could be used to prevent more unnecessary biopsies, as well as a decrease in missed PCa cases, without omitting any high-grade prostate cancer (HGPCa) above 20% threshold probability in the PSA 4-10 ng/ml cohort. This evidence concerns the gene KLK3 and prostate cancer.